Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

03.03.21	Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment- Quick Facts (RTTNews)
03.03.21	Lilly : Phase 3 Study On Baricitinib Meets Primary Endpoint Of Hair Regrowth (RTTNews)
26.02.21	Eli Lilly: U.S. Govt. To Buy Min. 100K Doses Of Bamlanivimab 700 Mg, Etesevimab 1400 Mg Together (RTTNews)
19.02.21	FLXN On Track, IMNM Discovers Antibodies To Fight S. African Variant, RIGL In Deal With LLY (RTTNews)
18.02.21	Lilly, Rigel To Develop RIPK1 Inhibitors For Treatment Of Immunological & Neurodegenerative Diseases (RTTNews)
17.02.21	Eli Lilly: Tirzepatide Significantly Reduced A1C And Body Weight In Two Phase 3 SURPASS Trials (RTTNews)
10.02.21	GMDA On Track, GNFT Soars, HTBX Sparkles, LLY's Neutralizing Antibody Therapies Get FDA Nod (RTTNews)
10.02.21	Lilly's COVID-19 Antibody Combination Receives Emergency Use Authorization In U.S. (RTTNews)
09.02.21	Eli Lilly Appoints Anat Ashkenazi To Succeed Josh Smiley As CFO - Quick Facts (RTTNews)
29.01.21	Eli Lilly Q4 Results Top Estimates; Backs FY21 Outlook (RTTNews)
29.01.21	Eli Lilly And Co. Q4 adjusted earnings Beat Estimates (RTTNews)
28.01.21	Lilly To Buy Exclusive Rights For Chronic Pain Drug Candidate From Asahi Kasei Pharma (RTTNews)
28.01.21	AGTC Sheds Light On Achromatopsia Trials, LLY, VIR And GSK Team Up, CVM Turns Head As It Awaits Data (RTTNews)
27.01.21	Lilly, Vir Biotechnology, GSK Say First Patient Dosed In Expanded BLAZE-4 Trial - Quick Facts (RTTNews)
26.01.21	Eli Lilly: Phase 3 BLAZE-1 Trial Meets Primary And Secondary Endpoints (RTTNews)
22.01.21	Lilly Closes Acquisition Of Prevail Therapeutics (RTTNews)
22.01.21	ADMP's Symjepi Hits Walgreen's Shelves, LLY's Antibody Cuts COVID-19 Risk By 80%, FLDM On Watch (RTTNews)
21.01.21	Eli Lilly: Bamlanivimab Reduced Risk Of Contracting COVID-19 At Nursing Homes By Up To 80% (RTTNews)
19.01.21	Lilly, Merus Collaborate To Discover T-Cell Re-Directing Bispecific Antibodies (RTTNews)
15.01.21	Eli Lilly Invests In Unseen Capital Health Fund As Part Of Racial Justice Efforts (RTTNews)
12.01.21	BGNE Teams Up With NVS, Editas Slumps Over 15%, LLY's Drug Shines In TRAILBLAZER-ALZ, MESO On Watch (RTTNews)
11.01.21	Stock Alert: Eli Lilly And Company Jumps 11% (RTTNews)
11.01.21	Eli Lilly: FDA Accepts Supplemental New Drug Application For Jardiance - Quick Facts (RTTNews)
11.01.21	Lilly's Donanemab Slows Clinical Decline Of Alzheimer's Disease In Phase 2 Trial (RTTNews)
15.12.20	Lilly Raises 2020 Outlook; Sees 2021 In Line With View - Quick Facts (RTTNews)
15.12.20	Eli Lilly To Acquire Prevail Therapeutics - Quick Facts (RTTNews)
09.12.20	Lilly : Verzenio - Standard Endocrine Therapy Combination Reduces Breast Cancer Recurrence Risk (RTTNews)
09.12.20	Lilly's Tirzepatide Significantly Reduces A1C And Body Weight In People With Type 2 Diabetes (RTTNews)
07.12.20	Loxo Oncology Announces Data From The Phase 1/2 Trial For LOXO-305 In Chronic Lymphocytic Leukemia (RTTNews)
04.12.20	Lilly, UnitedHealth Partner On Pragmatic Study Of Bamlanivimab For COVID-19 (RTTNews)
20.11.20	Lilly, Precision BioSciences Reach Genome Editing Research Collaboration And License Deal (RTTNews)
20.11.20	AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B (RTTNews)
20.11.20	FDA Issues Emergency Approval To Lilly's Arthritis Drug With Remdesivir For COVID-19 Treatment (RTTNews)
19.11.20	Lilly Partners Ypsomed To Offer Automated Insulin Delivery System For Diabetes Patients (RTTNews)
18.11.20	Eli Lilly : Jardiance Reduces Risk Of First Plus Recurrent Cardiovascular Events (RTTNews)
10.11.20	ARNA Falls Short Of ADVICE, PFE's COVID-19 Vaccine Shows 90% Efficacy, SUPN Hit By Double Whammy (RTTNews)
10.11.20	Lilly's COVID-19 Antibody Drug Gets FDA Emergency Use Authorization For Non-hospitalized Patients (RTTNews)
30.10.20	Lilly, Incyte Report Positive New Data For Baricitinib In Adult Patients With Alopecia Areata (RTTNews)
28.10.20	Eli Lilly's Bamlanivimab Phase 2 Study Data Shows Treatment May Be Effective Against COVID-19 (RTTNews)
28.10.20	Lilly In Deal To Supply 300,000 Vials Of COVID-19 Drug Bamlanivimab To U.S. Govt For $375 Mln (RTTNews)
27.10.20	Eli Lilly Q3 Profit Misses Estimates; Revenue Up 5% (RTTNews)
27.10.20	Eli Lilly And Co. Q3 adjusted earnings Miss Estimates (RTTNews)
27.10.20	Eli Lilly Ends Late-stage Covid-19 Antibody Trial In U.S. Due To Insufficient Data (RTTNews)
16.10.20	SNY/TBIO Move COVID-19 Vaccine Into Clinic, AVXL's PDD Study Promising, EIGR On Watch (RTTNews)
15.10.20	Lilly To Buy Disarm Therapeutics For Upfront Payment Of $135.0 Mln (RTTNews)
14.10.20	LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS (RTTNews)
12.10.20	Eli Lilly Reports Data From Phase 2 SERENITY Study Evaluating Mirikizumab (RTTNews)
09.10.20	Innovent, Eli Lilly Announce Approval Of HALPRYZA In China - Quick Facts (RTTNews)
09.10.20	Eli Lilly: Nearly 4 Out Of 5 People In OVERCOME Survey Report Improvement In Migraine (RTTNews)
08.10.20	Lilly, Gates Foundation To Supply Potential COVID-19 Therapy For Low, Middle Income Countries (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus
20.12.24		Handel in Zürich: SMI verbucht Verluste
20.12.24		Zurückhaltung in Europa: Euro STOXX 50 präsentiert sich schwächer

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus